User login
- /content/company-withdraws-application-idelalisib
- /hematology-oncology/article/185103/leukemia-myelodysplasia-transplantation/company-withdraws
- /hematologytimes/article/185103/leukemia-myelodysplasia-transplantation/company-withdraws-application
- /b-cell-lymphoma-icymi/article/185103/leukemia-myelodysplasia-transplantation/company-withdraws